Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Q32 Bio
Company

Q32 Bio

Tracked across 1 events · 6 articles · First seen Jul 13, 2026 · Last active Jul 14, 2026

Sentiment
83
Attention
3
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
3 83
Business
Q32 Bio alopecia drug trial positive
Impact: Q32 Bio is the developer of bempikibart; positive trial data led to an 83% stock surge and plans for a registration-directed program.
Jul 13, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Q32 Bio live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.